Altogether, these findings illustrated that miR-613 diminishes the radiosensitivity of NPC cells by inhibiting the DNMT3B/TIMP3 via activation of the STAT1/FOXO1 pathway for the first time. The gene discussed is FOXO1; the disease is nasopharyngeal carcinoma.